← Back to Search

Intraocular Lens

AcrySof IQ Vivity IOL for Presbyopia

N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
22 years old or older at Visit 1
Implantation of AcrySof IQ Vivity and/or Vivity Toric IOL models in both eyes for 3 to 5 years prior to enrollment
Must not have
Corneal refractive surgery after AcrySof Vivity or AcrySof Vivity Toric IOL implantation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1, year 3-5 postoperative
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to study the long-term safety and effectiveness of two types of intraocular lenses called AcrySof IQ Vivity and AcrySof IQ Vivity Toric in real-world clinical

Who is the study for?
This trial is for individuals who have had their natural lens removed (aphakia), struggle with near vision due to aging (presbyopia), or have blurred vision caused by an irregularly shaped cornea (astigmatism).
What is being tested?
The study is evaluating the long-term safety and effectiveness of AcrySof IQ Vivity Extended Vision IOLs, which are artificial lenses implanted in the eye to improve vision after cataract surgery.
What are the potential side effects?
While specific side effects are not listed here, common side effects of intraocular lens implantation can include visual disturbances like glare and halos, mild discomfort, redness, and risk of infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 22 years old or older.
Select...
I have had Vivity lens implants in both eyes for 3-5 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I had eye surgery to correct my vision after getting a Vivity lens implant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1, year 3-5 postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1, year 3-5 postoperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of adverse events
Incidence of device deficiencies
Mean Binocular Best Corrected Distance Visual Acuity (BCDVA) at Visit 1

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AcrySof IQ Vivity Extended Vision IOL and AcrySof IQ Vivity Toric Extended Vision IOLExperimental Treatment1 Intervention
AcrySof IQ Vivity Extended Vision IOL implanted in both eyes during cataract surgery

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
731 Previous Clinical Trials
128,699 Total Patients Enrolled
19 Trials studying Aphakia
6,056 Patients Enrolled for Aphakia
Clinical Trial Management Operations, SurgicalStudy DirectorAlcon Research, LLC
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Aphakia
100 Patients Enrolled for Aphakia
~140 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top